Monthly Archives: January 2006
Sulfonylurea drugs, used in the treatment of patients with diabetes mellitus to lower blood sugar levels, have been suspected since the 1970s of increasing cardiovascular mortality as well.
Roche Diagnostics has initiated a worldwide voluntary recall of specific ACCU-CHEK Aviva Meters because of the potential for an electronic malfunction which can cause the meter to report an erroneous result or shut down and no longer be used.
While their findings could provide new insight into mammalian hibernation, researchers note that the pivotal metabolic signal that emerged from the dark also presents a new target for obesity and type 2 diabetes research.
Results of study suggest that restoring fatty-acid levels in the brain may be a promising way to treat obesity.
Eating a very low-calorie yet nutritionally balanced diet is good for your heart. Studying heart function in members of an organization called the Caloric Restriction Society, investigators found that their hearts functioned like the hearts of much younger people.
The brain plays a major role in the ability of insulin therapy to lower blood sugar in animals with diabetes, according to a new study.
Obese and overweight individuals suffering metabolic syndrome and Type 2 diabetes showed significant health improvements after only three weeks of diet and moderate exercise even though the participants remained overweight.
Research on one promising new treatment uses a growing body of evidence that inflammation may be a key cause of diabetic kidney disease.
Doctors suggest a new approach to weight loss based on a recent study showing that a low-fat vegan diet is an effective way to shed unwanted pounds.
GlaxoSmithKline and FDA notified healthcare professionals about post-marketing reports of new onset and worsening diabetic macular edema for patients receiving rosiglitazone.